Cover Image

Three-year follow-up of a randomized phase II trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine (the TREAT study)

Saved in:
Bibliographic Details
Main Authors: Kreuter, Michael (Author) , Vansteenkiste, Johan F. (Author) , Fischer, Jürgen (Author) , Eberhardt, Wilfried E. E. (Author) , Zabeck, Heike (Author) , Kollmeier, Jens (Author) , Serke, Monika (Author) , Frickhofen, Norbert (Author) , Reck, Martin (Author) , Engel-Riedel, Walburga (Author) , Neumann, Silke (Author) , Thomeer, Michiel (Author) , Schumann, Christian (Author) , DeLeyn, Paul (Author) , Graeter, Thomas (Author) , Stamatis, Georgios (Author) , Griesinger, Frank (Author) , Thomas, Michael (Author)
Format: Article (Journal)
Language:English
Published: 2016
In: Journal of thoracic oncology
Year: 2016, Volume: 11, Issue: 1, Pages: 85-93
ISSN:1556-1380
DOI:10.1016/j.jtho.2015.09.014
Online Access:Resolving-System, Volltext: https://doi.org/10.1016/j.jtho.2015.09.014
Get full text
Author Notes:Michael Kreuter MD, Johan Vansteenkiste MD, Jürgen R. Fischer MD, Wilfried E. Eberhardt MD, Heike Zabeck MD, Jens Kollmeier MD, Monika Serke MD, Norbert Frickhofen MD, Martin Reck MD, Walburga Engel-Riedel MD, Silke Neumann MD, Michiel Thomeer MD, Christian Schumann MD, Paul De Leyn MD, Thomas Graeter MD, Georgios Stamatis MD, Frank Griesinger MD, Michael Thomas MD, on behalf of the TREAT investigators
Description
Physical Description:Online Resource
ISSN:1556-1380
DOI:10.1016/j.jtho.2015.09.014

Similar Items